**Executive Summary**
A Chintan Shivir was organized by the Department of Commerce on March 14, 2026, to strategize on strengthening India's medical devices export ecosystem. The event aimed to achieve a USD 30 billion market size by 2030 and involved deliberations on policy, regulation, and infrastructure to boost global competitiveness. Key action items include fostering government-industry collaboration and addressing structural issues to expedite export growth.
**Key Points / Main Content**
* **Event Purpose and Scope:**
* Organized by the Department of Commerce, in collaboration with the Department of Pharmaceuticals and the Export Promotion Council for Medical Devices (EPCMD).
* Aimed to identify policy priorities, address regulatory and infrastructure bottlenecks, and explore opportunities for the medical devices manufacturing ecosystem and export capabilities.
* Discussions were held under the theme "Achieving 30@2030 USD 30 Billion Market Size by 2030."
* Attended by over 150 participants from government, industry, regulatory bodies, and the broader medical devices ecosystem.
* **Objectives and Vision:**
* To transition India from being the "Pharmacy of the World" to a global MedTech manufacturing hub.
* To significantly enhance India's global market share over the next decade.
* Focus on high-value manufacturing, research and development, incremental innovation, and regulatory harmonization.
* Leverage India's significant domestic market for scaling.
* **Thematic Sessions:**
* **"Global Trade Deals and India's MedTech Exports: New Pathways Opened by Global FTAs":** Deliberated on opportunities from expanding trade agreements and strategies for market access.
* **"MedTech Export Infrastructure and Global Brand Building":** Highlighted the need for strengthening manufacturing clusters, expanding testing infrastructure, and building global brand recognition.
* **"Evolving Regulatory Frameworks to Support Medical Device Exports":** Emphasized regulatory harmonization, streamlining approval processes, and improving coordination between industry and regulators.
* **Outcome and Next Steps:**
* Discussions focused on actionable pathways to strengthen the medical devices manufacturing ecosystem and enhance export competitiveness.
* Learnings will help the Department of Commerce leverage industry advantages and promote a vibrant export ecosystem through active engagement with the Department of Pharmaceuticals, CDSCO, and EPCMD.
**Impact Analysis**
* **Government Stakeholders (Department of Commerce, Department of Pharmaceuticals, DGFT, CDSCO):**
* **Impact:** Informed about key policy priorities, regulatory challenges, and infrastructure needs to formulate strategies and initiatives for strengthening the medical devices export ecosystem.
* **Action Required:** Active engagement and collaboration with the industry and other stakeholders to implement identified pathways and leverage industry advantages.
* **Industry Stakeholders (Medical Device Manufacturers, Exporters, Sector Experts):**
* **Impact:** Provided a platform to voice concerns, share perspectives, and contribute to policy formulation. Will benefit from potential policy changes, improved infrastructure, and enhanced market access.
* **Action Required:** Continued collaboration with the government and regulatory bodies to address global regulatory challenges, scale domestic manufacturing, and build global brand recognition.
* **Regulatory Bodies (EPCMD, CDSCO):**
* **Impact:** Involved in discussions to streamline approval processes, harmonize regulations, and improve coordination with the industry.
* **Action Required:** Work towards evolving regulatory frameworks to support medical device exports and facilitate smoother export processes.
Key Entities Referenced
Chintan Shivir on Strengthening India's Medical Devices Export Ecosystem: An event organized by the Department of Commerce to discuss strategies for strengthening India's medical devices export ecosystem.
Department of Commerce: The primary organizing body of the Chintan Shivir and responsible for the policy's scope.
Department of Pharmaceuticals: A key collaborator in the organization of the Chintan Shivir and involved in the medical devices sector.
Export Promotion Council for Medical Devices (EPCMD): A collaborating organization and a key stakeholder in the medical devices export ecosystem.
Directorate General of Foreign Trade (DGFT): An entity whose representative, Shri Lav Aggarwal, spoke about trade policy and export promotion.
Ministry of Commerce & Industry
Department of Commerce organizes Chintan
Shivir on strengthening India’s Medical Devices
export ecosystem
India’s medical device exports cross USD 4 billion in FY25;
focus on scaling global market share: Secretary, Department
of Commerce
Posted On: 14 MAR 2026 9:04PM by PIB Delhi
A Chintan Shivir on “Strengthening India’s Medical Devices Export Ecosystem” was organized by the
Department of Commerce in collaboration with the Department of Pharmaceuticals and the Export
Promotion Council for Medical Devices (EPCMD) at Vanijya Bhawan, New Delhi today. The event
brought together policymakers, regulators, industry leaders, exporters and sector experts to deliberate on
strategies for strengthening India’s global competitiveness in the MedTech sector.
The discussions were held under the theme “Achieving 30@2030 – USD 30 Billion Market Size by
2030.” The event witnessed participation of over 150 participants from government, industry, regulatory
bodies and the broader medical devices ecosystem.
The Chintan Shivir served as a platform for structured engagement between the Government and industry
stakeholders to identify key policy priorities, address regulatory and infrastructure bottlenecks, and
explore emerging opportunities for strengthening India’s medical devices manufacturing ecosystem and
export capabilities.
India’s medical devices sector has emerged as a critical component of the country’s healthcare and
manufacturing landscape. With growing global demand for affordable and high-quality medical
technologies, India is increasingly positioning itself as a reliable manufacturing and export hub.
In the inaugural session, Forum Coordinator, AiMeD, Shri Rajiv Nath shared the industry perspective and
emphasized the need for continued government–industry collaboration to address global regulatory
challenges and scale domestic manufacturing.
Addressing the gathering, Joint Secretary, Department of Pharmaceuticals, Shri Aman Sharma highlighted
the importance of focusing on the quality of medical devices manufacturing in the country and
emphasized that both industry and regulators need to work together towards this objective.
Delivering the special address, Additional Secretary and Director General, Directorate General of Foreign
Trade (DGFT), Shri Lav Aggarwal emphasized the need to grow faster by addressing structural issues. He
highlighted the role of trade policy measures and export promotion initiatives in expanding India’s
presence in global medical devices markets.The Chintan Shivir was formally inaugurated by Secretary, Department of Commerce, Shri Rajesh
Agarwal. In his inaugural address, he emphasized that India must move beyond its identity as the
“Pharmacy of the World” to emerge as a global MedTech manufacturing hub.
Noting that India’s medical device exports have crossed USD 4 billion in FY25, Shri Agarwal highlighted
the need to significantly enhance India’s global market share over the next decade with a strong focus on
high-value manufacturing, research and development investments, incremental innovation and regulatory
harmonization. He also emphasized the broader goal of achieving a USD 30 billion medical devices
market by 2030 while leveraging India’s significant domestic market for scaling.
The Chintan Shivir featured three thematic sessions focusing on key aspects of strengthening India’s
medical devices export ecosystem.
The first session, titled “Global Trade Deals and India’s MedTech Exports: New Pathways Opened by
Global FTAs,” deliberated on opportunities emerging from India’s expanding network of trade agreements
and strategies for enhancing market access in global markets.
The second session focused on “MedTech Export Infrastructure and Global Brand Building,” highlighting
the need to strengthen manufacturing clusters, expand testing infrastructure and build global brand
recognition for Indian medical devices.
The third session discussed “Evolving Regulatory Frameworks to Support Medical Device Exports,” with
emphasis on regulatory harmonization, streamlining approval processes and improving coordination
between industry and regulators to facilitate exports.
The Chintan Shivir concluded with discussions on actionable pathways for strengthening India’s medical
devices manufacturing ecosystem and enhancing export competitiveness. The learnings from the Chintan
Shivir will help the Department of Commerce leverage the advantages of India’s medical devices industry
and promote a vibrant export ecosystem through active engagement with the Department of
Pharmaceuticals, CDSCO and EPCMD.
***
Abhishek Dayal/ Shabbir A(Release ID: 2240258) Visitor Counter : 232